ABALONYX AS

Their core work

Abalonyx is a Norwegian SME specializing in graphene oxide production and advanced carbon nanomaterials. Their core business centers on manufacturing reduced graphene oxide (rGO) at industrial scale, as evidenced by their perGOla project where they served as coordinator. They supply these materials into diverse application chains — from CO2 capture adsorbents and 3D-printed hybrid structures to wearable biomedical electronics — acting as a materials provider that enables downstream innovation across multiple sectors.

What they specialise in

How they've shifted over time

In their early H2020 period (2015–2019), Abalonyx focused on industrial material applications — additive manufacturing scaffolds (FAST) and carbon nanomaterial-based CO2 capture systems (CARMOF), working with ceramics, steel, and hybrid structures. By 2019, they shifted toward biomedical and electronics applications with WEARPLEX, while simultaneously launching perGOla to scale up their core graphene oxide production. This suggests a company maturing from downstream application projects toward owning their position as a graphene oxide supplier while exploring higher-value markets like wearable health tech.

Abalonyx is moving from being a materials participant in others' projects toward becoming a standalone graphene oxide producer targeting biomedical and electronics markets.

How they like to work

Abalonyx primarily operates as a specialist partner, joining consortia (3 of 4 projects) where their nanomaterial expertise fills a specific supply-chain gap. They coordinated once — perGOla, an SME Phase 1 feasibility study — which signals ambition to lead their own commercialization path. With 35 unique partners across 15 countries from just 4 projects, they integrate well into large European consortia and appear comfortable working with diverse, international teams.

Despite only 4 projects, Abalonyx has built a broad network of 35 partners spanning 15 countries, indicating participation in sizeable multi-national consortia. Their reach is firmly pan-European with no obvious geographic clustering.

What sets them apart

Abalonyx occupies a rare niche: they are one of very few European SMEs focused on large-scale graphene oxide production, positioning them as a critical materials supplier for any consortium needing carbon nanomaterials. Their cross-domain experience — from CO2 capture to biomedical electrodes — demonstrates that their materials platform is versatile, not locked to a single application. For consortium builders, they bring both the material itself and practical knowledge of integrating it into 3D printing, membrane, and flexible electronics workflows.

Highlights from their portfolio

• perGOla
  Their only coordinated project — an SME Phase 1 feasibility study for large-scale reduced graphene oxide manufacturing, representing their core commercial ambition.
• CARMOF
  Largest funding (EUR 272K) and most technically rich project, combining carbon nanotubes, metal-organic frameworks, 3D printing, and membrane technology for CO2 capture.
• WEARPLEX
  Signals a strategic pivot into biomedical wearables — a higher-value market for their graphene-based materials.